G. Prelevic

发表

M. Andrikoula, G. Prelevic, G. Prelević, 2009, Climacteric : the journal of the International Menopause Society.

Menopausal hot flush: Is it only a nuisance or also a marker of cardiovascular disease risk?

P. Hardiman, M. Andrikoula, G. Prelevic, 2009, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Hormone replacement therapy in postmenopausal women.

A. Markou, T. Kocjan, G. Prelevic, 2005, Minerva endocrinologica.

Hormone replacement therapy update: who should we be prescribing this to now?

T. Kocjan, G. Prelevic, G. Prelević, 2003, Current opinion in obstetrics & gynecology.

Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors in women with glucose intolerance in pregnancy and normal controls.

M. Bieńkiewicz, M. Press, K. Lewandowski, 2009 .

Cardiac flow velocity in women with the polycystic ovary syndrome

G. Prelevic, J. Ginsburg, Teodora Beijic, 1995, Clinical endocrinology.

Effects of hormone replacement therapy type and route of administration on plasma matrix metalloproteinases and their tissue inhibitors in postmenopausal women.

H. Randeva, A. Lewiński, M. Bieńkiewicz, 2006, The Journal of clinical endocrinology and metabolism.

Exercise and the Skeleton,17 November 1998, London, UK

C. Bartram, K. Brooke-Wavell, G. Prelevic, 1999, Osteoporosis International.

The effects of micronutrient supplementation on vasomotor symptoms in postmenopausal women

T. Duka, L. Liao, J. Nešić, 2011, Climacteric : the journal of the International Menopause Society.

Osteopenia as a feature of the androgen insensitivity syndrome

G. Conway, S. Soule, H. Jacobs, 1995, Clinical endocrinology.

Comparative effects on bone mineral density of tibolone, transdermal estrogen and oral estrogen/progestogen therapy in postmenopausal women.

C. Bartram, J. Wood, G. Prelevic, 1996, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

The effect of tibolone on bone mineral density in postmenopausal women with osteopenia or osteoporosis--8 years follow-up.

C. Bartram, A. Markou, G. Prelevic, 2004, Maturitas.

Testosterone levels after bromocriptine treatment in patients undergoing long-term hemodialysis.

L. Djukanovic, L. Perić, G. Prelevic, 1985, Journal of andrology.

Metabolic effects of tibolone in postmenopausal women with non-insulin dependent diabetes mellitus.

G. Prelevic, J. Ginsburg, T. Beljić, 1998, Maturitas.

The effect of tibolone on cardiac flow in postmenopausal women with non-insulin dependent diabetes mellitus.

G. Prelevic, J. Ginsburg, T. Beljić, 1997, Maturitas.

Is there a proven place for phytoestrogens in the menopause?

G. Prelevic, J. Ginsburg, 1999, Climacteric : the journal of the International Menopause Society.

Elevated concentrations of retinol-binding protein-4 (RBP-4) in gestational diabetes mellitus: Negative correlation with soluble vascular cell adhesion molecule-1 (sVCAM-1)

H. Randeva, P. O’Hare, M. Bieńkiewicz, 2008, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

The role of metformin in the management of polycystic ovary syndrome

T. Tsilchorozidou, G. Prelevic, G. Prelević, 2003, Current opinion in obstetrics & gynecology.

Renovascular hypertension associated with bilateral aldosteronoma.

L. Perić, P. Bojić, G. Prelevic, 1984, Postgraduate medical journal.

Effects of a Iow-dose estrogen-antiandrogen combination (Diane-35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome

G. Prelevic, L. Balint-perić, M. Würzburger, 1990 .

Insulin resistance in polycystic ovary syndrome

G. Prelevic, 1997, Current opinion in obstetrics & gynecology.

Human growth hormone and restoration of hypoglycaemia awareness

B. Frier, P. Sönksen, D. Hepburn, 1992, The Lancet.

Lack of significant hormonal effects and controlled trials of phyto-oestrogens

G. Prelevic, J. Ginsburg, G. Prelević, 2000, The Lancet.

Restoration of hypoglycaemia awareness by human recombinant growth hormone

P. Sőnksen, G. Prelevic, M. Wurzburger, 1992, The Lancet.

Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance

H. Randeva, A. Lewiński, M. Vatish, 2007, Diabetologia.

EFFECTS OF IMPROVED BLOOD GLUCOSE ON INSULIN‐INDUCED HYPOGLYCAEMIA, TRH, GnRH AND EXERCISE TESTS IN INSULIN‐DEPENDENT DIABETES

P. Sönksen, R. Morris, L. Perić, 1990, Clinical endocrinology.

THE EFFECTS OF IMPROVED BLOOD GLUCOSE ON GROWTH HORMONE AND CORTISOL SECRETION IN INSULIN‐DEPENDENT DIABETES MELLITUS

P. Sönksen, R. Morris, L. Perić, 1990, Clinical endocrinology.

A case–control study assessing bone mineral density in severe haemophilia A in the UK

P. McLaughlin, P. Prouse, S. Gill, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Vitamin D status in patients with osteopenia or osteoporosis--an audit of an endocrine clinic.

G. Conway, T. Kocjan, T. Tan, 2006, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

Serum levels of matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors in women with glucose intolerance in pregnancy and normal controls

M. Bieńkiewicz, M. Press, K. Lewandowski, 2010 .

Clinical experience with tibolone (Livial) over 8 years.

D. Butler, G. Prelevic, J. Ginsburg, 1995, Maturitas.

The effect of recombinant human growth hormone on regulation of growth hormone secretion and blood glucose in insulin-dependent diabetes.

P. Sönksen, M. Wheeler, G. Prelevic, 1993, The Journal of clinical endocrinology and metabolism.

Tibolone in Postmenopausal Women with a History of Breast Carcinoma

G. Prelevic, J. Ginsburg, G. Prelević, 1995 .

BRIEF REPORT Increased Circulating Levels of Matrix Metalloproteinase-2 and -9 in Women with the Polycystic Ovary Syndrome

H. Randeva, B. Tan, J. Komorowski, 2006 .

The influence of physical activity on the response of bone mineral density to 5 years tibolone.

C. Bartram, K. Brooke-Wavell, G. Prelevic, 2000, Maturitas.

Increased circulating levels of matrix metalloproteinase-2 and -9 in women with the polycystic ovary syndrome.

H. Randeva, C. O’Callaghan, B. Tan, 2006, The Journal of clinical endocrinology and metabolism.

Effect of recombinant human growth hormone treatment on insulin-like growth factor (IGF-I) levels in insulin-dependent diabetic patients

P. Sönksen, M. Wheeler, G. Prelevic, 1995, Acta Diabetologica.

Growth Hormone Levels in Patients with Type 1 Diabetes are Age Related

P. Sőnksen, G. Prelevic, L. Balint-perić, 1993, Diabetic medicine : a journal of the British Diabetic Association.

Effect of two different progestins (cyproterone acetate and norgestrel), administered in a cyclical estradiol valerate regimen, on markers of bone turnover.

G. Prelevic, T. Beljić, L. Balint-perić, 1994, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Inhibitory effect of sandostatin on secretion of luteinising hormone and ovarian steroids in polycystic ovary syndrome

J. Nešić, G. Prelevic, L. Balint-perić, 1990, The Lancet.

Prevalence of polycystic ovaries and polycystic ovary syndrome in lesbian women compared with heterosexual women.

G. Conway, A. Balen, J. Bekir, 2004, Fertility and sterility.

Metoclopramide effect on serum prolactin, LH and FSH in patients with polycystic ovary syndrome

L. Perić, G. Prelevic, G. Prelević, 1988, Journal of endocrinological investigation.

Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome

L. Perić, G. Prelevic, G. Prelević, 1987, Journal of endocrinological investigation.

Delayed-type allergy against various insulin preparations including human semisynthetic insulin.

G. Prelevic, S. Vuckovic, D. Nastić-Mirić, 1987, Annals of allergy.

Prolactinoma and pregnancy

H. Randeva, G. Prelevic, Mel A. Davis, 2000, BJOG : an international journal of obstetrics and gynaecology.

Estrogens and brain function.

T. Duka, A. Markou, G. Prelevic, 2005, Hormones.

Effects of physical activity and menopausal hormone replacement therapy on postural stability in postmenopausal women--a cross-sectional study.

K. Brooke-Wavell, G. Prelevic, J. Ginsburg, 2001, Maturitas.

Double-blind, placebo-controlled study of the effects of tibolone on bone mineral density in postmenopausal osteoporotic women with and without previous fractures.

P. Pavlov, H. Bennink, G. Prelevic, 1999, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Cause of vaginal bleeding in postmenopausal women taking tibolone.

G. Prelevic, J. Ginsburg, G. Prelević, 1996, Maturitas.

Effect of tibolone on markers of cardiovascular disease risk in postmenopausal women undergoing hemodialysis: a pilot study.

D. Mikhailidis, J. Ostberg, N. Dimkovic, 2004, Fertility and sterility.

A cross-sectional study of the effects of hormon replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women.

D. Mikhailidis, I. Jagroop, G. Prelevic, 2002, Fertility and sterility.

Antiatherosclerotic effects of tibolone.

G. Prelevic, J. Ginsburg, 2001, Menopause.

Exercise and body image distress in overweight and obese women with polycystic ovary syndrome: A pilot investigation

L. Liao, K. Brooke-Wavell, J. Nešić, 2008, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome.

H. Randeva, J. Drzewoski, L. Czupryniak, 2002, The Journal of clinical endocrinology and metabolism.

Gonadal Dysfunction in Patients with Myotonic Dystrophy

Z. Marinković, G. Prelevic, S. Nogić, 1990, Experimental and clinical endocrinology.

Cushing's syndrome--transitory immune deficiency state?

G. Prelevic, S. Vuckovic, M. Würzburger, 1986, Postgraduate medical journal.

The Effects of Intranasal Salmon Calcitonin on Bone Metabolism in Women with Premature Menopause

G. Prelevic, L. Balint-perić, J. Petrović, 1990 .

Osteoporosis in Men

G. Prelevic, G. Prelević, 2001, Journal of the Royal Society of Medicine.

Effects of the somatostatin analogue, octreotide, in polycystic ovary syndrome.

P. Hardiman, G. Prelevic, J. Ginsburg, 1992, Metabolism: clinical and experimental.